Adrenal suppression and Cushing's syndrome secondary to ritonavir and budesonide.
Gray
D
D
Roux
P
P
Carrihill
M
M
Klein
M
M
D000309:Adrenal Insufficiency / Q000139:chemically induced*; D001989:Bronchiolitis Obliterans / Q000150:complications / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000009:adverse effects*; D019819:Budesonide / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003480:Cushing Syndrome / Q000139:chemically induced*; D004347:Drug Interactions; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D012221:Rhinitis, Allergic, Perennial / Q000150:complications / Q000188:drug therapy*; D019438:Ritonavir / Q000009:adverse effects*
D001993:Bronchodilator Agents; D017320:HIV Protease Inhibitors; D019819:Budesonide; D019438:Ritonavir